Lowering of plasma concentrations of (+)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid (naproxen) by aspirin in rats.
D000284:Administration, Oral; D000818:Animals; D001241:Aspirin / Q000008:administration & dosage / Q000494:pharmacology*; D001798:Blood Proteins / Q000378:metabolism; D002247:Carbon Isotopes; D004347:Drug Interactions; D066298:In Vitro Techniques; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008297:Male; D008738:Methyl Ethers / Q000037:antagonists & inhibitors / Q000097:blood / Q000652:urine; D009281:Naphthalenes / Q000037:antagonists & inhibitors / Q000097:blood / Q000652:urine; D011422:Propionates / Q000037:antagonists & inhibitors / Q000097:blood* / Q000652:urine; D011485:Protein Binding; D051381:Rats; D012459:Salicylates / Q000097:blood / Q000494:pharmacology; D013997:Time Factors; D014316:Tritium
D001798:Blood Proteins; D002247:Carbon Isotopes; D008738:Methyl Ethers; D009281:Naphthalenes; D011422:Propionates; D012459:Salicylates; D014316:Tritium; D001241:Aspirin